IBRX Operating Cash Flow Growth
Immunitybio Inc · Operating Cash Flow Growth
IBRX Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported19.57%period ending
IBRX TTM Cash from Operations YoY % (-372.64% → 19.57%)
Year-over-year change
High-resolution chart · PNG
IBRX operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 19.5733% | |
| 20.4693% | |
| 22.0583% | |
| 24.1267% | |
| 14.7426% | |
| 4.9483% | |
| -6.6744% | |
| -23.1289% | |
| -22.2393% | |
| -12.2633% | |
| -8.6658% | |
| -7.4719% | |
| -8.0097% | |
| -20.0807% | |
| -22.9904% | |
| -22.289% | |
| -38.2259% | |
| -43.6599% | |
| -59.8024% | |
| -101.8402% | |
| -106.895% | |
| -153.2856% | |
| -179.854% | |
| -113.1962% | |
| -76.5368% | |
| -30.2602% | |
| 3.1855% | |
| 3.9341% | |
| -10.7273% | |
| -12.3797% | |
| -29.9323% | |
| -37.2497% | |
| -19.609% | |
| -36.2869% | |
| -26.396% | |
| -17.9011% | |
| -43.2542% | |
| -48.2638% | |
| -52.5114% | |
| -132.0279% | |
| -143.7044% | |
| -113.2867% | |
| -372.6373% |